Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3367
Actual shortage: 219 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 3138 (93%)

Discontinuation Reports

365
To be discontinued: 24 (7%)
Discontinued: 341 (93%)
Reversed: 0 (0%)

Late reports

144 (4%)

Overdue reports

68 (28%)
Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2023-02-16 2023-03-02 185025
APO-AMLODIPINE-ATORVASTATIN 20MG 10MG TABLET Resolved 2022-02-18 2022-04-01 155308
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2022-03-18 2022-04-01 156983
APO-AMLODIPINE-ATORVASTATIN 40MG 5MG TABLET Resolved 2022-06-06 2022-07-22 162088
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2022-06-06 2022-07-22 162091
APO-AMLODIPINE-ATORVASTATIN 20MG 10MG TABLET Resolved 2022-06-12 2022-07-22 162469
APO-AMLODIPINE-ATORVASTATIN 40MG 10MG TABLET Resolved 2022-12-02 2023-03-02 176924
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2019-12-12 2020-01-15 101082
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2019-12-12 2020-01-22 101088
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2020-07-08 2020-07-13 119677
APO-AMLODIPINE-ATORVASTATIN 10MG 40MG TABLET Resolved 2020-07-08 2020-07-13 119683
APO-AMLODIPINE-ATORVASTATIN 10MG 80MG TABLET Resolved 2020-07-08 2020-07-13 119687
APO-AMLODIPINE-ATORVASTATIN 5MG 80MG TABLET Resolved 2020-07-08 2020-07-13 119690
APO-AMLODIPINE-ATORVASTATIN 5MG 40MG TABLET Resolved 2021-04-23 2021-05-26 137956
APO-AMLODIPINE-ATORVASTATIN 10MG 10MG TABLET Resolved 2021-05-07 2021-05-26 138951
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2021-05-07 2021-05-26 138954
APO-AMLODIPINE-ATORVASTATIN 40MG 10MG TABLET Resolved 2021-05-14 2021-05-26 139400
APO-AMLODIPINE-ATORVASTATIN 80MG 10MG TABLET Resolved 2021-08-27 2021-11-19 144656
APO-AMLODIPINE-ATORVASTATIN 20MG 10MG TABLET Resolved 2021-10-01 2021-11-15 146500
APO-AMLODIPINE-ATORVASTATIN 80MG 5MG TABLET Resolved 2021-10-29 2021-11-08 148491

Showing 301 to 320 of 3367

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2018-09-07 2018-12-28 60603
APO-LOSARTAN/HCTZ 25MG 100MG TABLET Discontinued 2018-09-10 2018-12-28 60997
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO-MELOXICAM 7.5MG TABLET Discontinued 2018-09-07 2018-09-15 60612
APO-MEMANTINE 10MG TABLET Discontinued 2018-09-07 2018-09-15 60615
APO-METFORMIN - TAB 500MG 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40781
APO-METFORMIN - TAB 500MG 500MG TABLET To be discontinued 2018-02-23 2018-12-28 40784
APO-METFORMIN - TAB 500MG 500MG TABLET Discontinued 2018-02-23 2018-11-26 40790
APO-METFORMIN 850 MG TABLETS 850MG TABLET Discontinued 2018-02-23 2019-06-12 40778
APO-METFORMIN 850 MG TABLETS 850MG TABLET Discontinued 2018-02-23 2018-09-15 40796
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Discontinued 2019-01-04 2019-01-04 71207
APO-METOCLOP TAB 10MG 10MG TABLET Discontinued 2017-03-13 2017-03-13 1101
APO-METOCLOP TAB 5MG 5mg tablet Discontinued 2017-03-13 2017-03-13 1105
APO-METOPROLOL 25MG TABLET To be discontinued 2018-09-07 2021-06-03 60628
APO-MYCOPHENOLATE 250MG CAPSULE Discontinued 2018-09-07 2018-09-15 60637
APO-MYCOPHENOLATE 500MG TABLET Discontinued 2018-09-07 2018-10-12 60640
APO-NAPRO-NA 275MG TABLET Discontinued 2018-09-08 2018-09-15 60657
APO-NAPRO-NA DS 550MG TABLET Discontinued 2018-09-08 2018-09-15 60660
APO-NAPROXEN 250MG TABLET Discontinued 2018-09-08 2018-09-15 60666
APO-NEVIRAPINE XR 400MG TABLET (EXTENDED-RELEASE) Discontinued 2019-03-11 2019-03-11 78257

Showing 221 to 240 of 365